<unk>  is a monoclonal antibody that is FDA approved for the treatment of acute allograft rejection in renal transplant patients,  steroid-resistant acute allograft rejection in cardiac and hepatic transplant patients. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include edema , hypotension, tachycardia, rash,  diarrhea, nausea, vomiting, headache, tremor, fever, shivering.
Muromonab-CD3
Bavituximab
Cemiplimab-rwlc
Pertuzumab
Rituximab
Matuzumab
Elotuzumab
Alemtuzumab